News
The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.
Gilead Sciences (GILD) stock gains as Needham upgrades the company to Buy from Hold citing its new HIV prevention injectable, ...
LONDON -- The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, ...
Costa used pharmaceutical firms to divert HIV and cancer drugs across multiple states, selling patients medicine that was ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which ...
At the 6-month anniversary of the inauguration in January, The American Journal of Managed Care® looks back at the changes ...
Explore more
Responding to the sharp increase in new diagnoses, the Government of Fiji declared an HIV outbreak in January 2025. The HIV Outbreak Response Plan and the previously announced Counter Narcotics and ...
A federal judge extended a block on an Idaho law that uses an applicant’s immigration status to determine whether they’re ...
LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, ...
European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...
Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results